Clinical characteristics associated with anti-RNA pol III antibodies (multivariate analysis).
| Characteristic | OR (95% CI) | p |
|---|---|---|
| Diffuse cutaneous | 3.6 (1.4–9.5) | 0.009 |
| Pulmonary fibrosis | 0.4 (0.1–1.1) | 0.07 |
| Pulmonary arterial hypertension | 0.9 (0.1–7.8) | 0.96 |
| Scleroderma renal crisis | 4.8 (1.3–17.8) | 0.02 |